文献速递神经肿瘤

儿童低级别胶质瘤表观遗传与分子联合分析的临床影响

Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.
PubMed 文献 · Neuro Oncol · 2020-01-01

该研究对152例儿童低级别胶质瘤(PLGG)进行全基因组甲基化与分子分析,并结合长期临床随访,另从3个大型中心补充BRAF p.V600E突变等特定队列。无监督聚类发现5个新亚组,主要受肿瘤位置和淋巴细胞浸润等非肿瘤因素驱动;一个提示高淋巴细胞浸润的新甲基化簇进展无生存期更差(P=0.008;多因素分析P=0.035)。作者认为甲基化分类用于PLGG临床时,联合分子与病理分析是提供额外信息的关键。

要点

  • PLGG甲基化谱受肿瘤位置和淋巴细胞浸润等非肿瘤因素影响。
  • 高淋巴细胞浸润甲基化簇进展无生存期更差(P=0.008;多因素分析P=0.035)。
  • 现用甲基化分类器在44%病例置信度低,但对罕见病例重分类有帮助。

核心结论

  • PLGG甲基化谱受多种非肿瘤因素影响,联合分子与病理分析是甲基化分类用于临床时提供额外信息的关键。

研究设计与样本

  • 对152例PLGG(含40例节细胞胶质瘤)行全基因组甲基化与完整分子分析并长期临床随访,另从3个大型中心补充特定队列。

主要发现

  • 无监督层次聚类发现5个新PLGG亚组,主要由肿瘤位置和淋巴细胞浸润等非肿瘤因素主导:中线PLGG聚集,深部半球病灶与外周病灶不同。
  • 提示高淋巴细胞浸润的新甲基化簇经病理证实,与携带相似分子改变的PLGG相比进展无生存期更差(P=0.008;多因素分析:P=0.035)。
  • 现用甲基化分类器在44%病例中置信度低,对大多数PLGG未增加信息,但对罕见病例重分类有帮助。
  • 将组织病理和分子信息加入特定甲基化亚组(如多形性黄色星形细胞瘤样肿瘤)可将这些肿瘤分为低危和高危(P=0.0014)。

临床怎么用

  • 作者认为在临床环境中对PLGG使用甲基化分类时,联合分子和病理分析是提供额外信息的关键。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both genetic and methylation analysis have been shown to provide insight into the diagnosis and prognosis of many brain tumors. However, the implication of methylation profiling and its interaction with genetic alterations in pediatric low-grade gliomas (PLGGs) are unclear. METHODS: We performed a comprehensive analysis of PLGG with long-term clinical follow-up. In total 152 PLGGs were analyzed from a range of pathological subtypes, including 40 gangliogliomas. Complete molecular analysis was compared with genome-wide methylation data and outcome in all patients. For further analysis of specific PLGG groups, including BRAF p.V600E mutant gliomas, we compiled an additional cohort of clinically and genetically defined tumors from 3 large centers. RESULTS: Unsupervised hierarchical clustering revealed 5 novel subgroups of PLGG. These were dominated by nonneoplastic factors such as tumor location and lymphocytic infiltration. Midline PLGG clustered together while deep hemispheric lesions differed from lesions in the periphery. Mutations were distributed throughout these location-driven clusters of PLGG. A novel methylation cluster suggesting high lymphocyte infiltration was confirmed pathologically and exhibited worse progression-free survival compared with PLGG harboring similar molecular alterations (P = 0.008; multivariate analysis: P = 0.035). Although the current methylation classifier revealed low confidence in 44% of cases and failed to add information in most PLGG, it was helpful in reclassifying rare cases. The addition of histopathological and molecular information to specific methylation subgroups such as pleomorphic xanthoastrocytoma-like tumors could stratify these tumors into low and high risk (P = 0.0014). CONCLUSION: The PLGG methylome is affected by multiple nonneoplastic factors. Combined molecular and pathological analysis is key to provide additional information when methylation classification is used for PLGG in the clinical setting.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Fukuoka K, Mamatjan Y, Tatevossian R, et al. Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas. Neuro Oncol. 2020. PMID: 32242226. doi:10.1093/neuonc/noaa077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。